Show simple item record

FieldValueLanguage
dc.contributor.authorLipworth, W
dc.contributor.authorAxler, R
dc.date.accessioned2016-04-07
dc.date.available2016-04-07
dc.date.issued2016-03-01
dc.identifier.citationLipworth W, Axler R. Towards a bioethics of innovation. Journal of Medical Ethics, 2016 doi:10.1136/medethics-2015-103048, Published Online First 25 March 2016 at http://jme.bmj.com/content/early/2016/03/25/medethics-2015-103048.abstracten_AU
dc.identifier.urihttp://jme.bmj.com/content/early/2016/03/25/medethics-2015-103048.abstract
dc.identifier.urihttp://hdl.handle.net/2123/14648
dc.description.abstractIn recent years, it has become almost axiomatic that biomedical research and clinical practice should be ‘innovative’—that is, that they should be always evolving and directed towards the production, translation and implementation of new technologies and practices. While this drive towards innovation in biomedicine might be beneficial, it also raises serious moral, legal, economic and sociopolitical questions that require further scrutiny. In this article, we argue that biomedical innovation needs to be accompanied by a dedicated ‘bioethics of innovation’ that attends systematically to the goals, process and outcomes of biomedical innovation as objects of critical inquiry. Using the example of personalised or precision medicine, we then suggest a preliminary framework for a bioethics of innovation, based on the research policy initiative of ‘Responsible Innovation’. We invite and encourage critiques of this framework and hope that this will provoke a challenging and enriching new bioethical discourse.en_AU
dc.description.sponsorshipNHMRC APP1036539en_AU
dc.language.isoenen_AU
dc.publisherBMJ Publishing Groupen_AU
dc.titleTowards a bioethics of innovationen_AU
dc.typeArticleen_AU
dc.type.pubtypePost-printen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.